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Abstract Flavonoids have been studied as potential
agents in medicine for many years. Among them, genistein
was found to be active in various biological systems,
mainly in prevention of cancer. Our recent work supported
the idea that genistein also impacts multiple cellular pro-
cesses in healthy fibroblasts; however, its effects on cell
cycle-related pathways remained to be elucidated. Thus, in
this work, high throughput screening with microarrays
coupled to real-time quantitative Reverse Transcription
PCR analyses was employed to study the changes in ex-
pression of key genes associated with cell cycle regulation
and/or DNA replication in response to genistein,
kaempferol, daidzein, and mixtures of genistein and either
kaempferol or daidzein. Among them, genistein was found
as the most significantly modulating, in a time- and dose-
dependent manner, compound of activity of studied genes,
whose products are involved in different phases of the cell
cycle and/or in regulatory processes important for DNA
replication and cell growth. It considerably reduced the
efficiency of expression of genes coding for MCM2-7
and MCM10 helicases, as well as some other proteins
involved in the S phase control. In addition, genistein
caused cell cycle arrest in the G2/M phase, which was
accompanied by activation of CDKN1A, CDKN1C,
CDKN2A, CDKN2B, CDKN2C, and GADD45A genes, as
well as down-regulation of several mRNAs specific for this
stage, demonstrated by transcriptomic assessments. We
believe that studies described in this paper will be helpful
in elucidating molecular mechanisms of action of genistein
as modulator of cell cycle and inhibitor of DNA replication
in humans.
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Introduction
Compounds produced by one kind of organism (one spe-
cies) can significantly influence physiology of other spe-
cies. Interesting examples are plant-derived metabolites,
which have various biological activities and can affect
basic biological processes in humans [1]. In fact, such
compounds can be taken by humans with food, which in
turn has an impact on health condition of the human body.
Examples of bioactive plant metabolites are flavonoids [2].
This group consists of compounds that are considered as
therapeutic molecules for cancer, infections, and some
genetic diseases, for example, cystic fibrosis and mu-
copolysaccharidoses [3–5]. Therefore, determining
mechanisms of their biological activities is very important
to assess safety of these compounds and to develop optimal
therapeutic procedures. Interestingly, flavonoids can influ-
ence cell cycle and DNA metabolism, but detailed
mechanisms of their actions are not completely understood
[2]. Effects of plant metabolites, among them genistein, on
cell cycle and DNA replication have been studied in the
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light of human health, especially prevention of cancer [6–
11]. Genistein was found to inhibit cell division cycle and
DNA replication in eukaryotic cells when used at suffi-
ciently high concentrations [12, 13]. It was suggested that
such an action might be caused by blocking activity of
topoisomerase [14–17]. Genistein was also shown to ex-
hibit biological activity through inhibition of various ki-
nases [14, 18].
Recently, in order to investigate more extensively the
effects of genistein in cell culture models, we have used
DNA microarrays to assess the global effects of this
compound on RNA expression in fibroblasts obtained from
a healthy adult donor [19]. These studies supported the idea
that genistein impacts multiple cellular pathways; however,
its specificity and effects on cell cycle-related pathways
remained to be delineated. The cell cycle or cell division
cycle is the series of events that takes place in a cell leading
to its division and duplication. It is controlled by numerous
mechanisms ensuring correct cell splitting. Elucidation of
the global pattern of molecular changes caused by genistein
in respect to cell proliferation and DNA replication is de-
sired in the light of the complex nature of genistein’s
biological activity as well as its unique effects in various
biological systems, above all in humans. We found this
topic interesting in respect not only to genistein, but also to
other flavonoids, kaempferol, and daidzein, likewise mix-
tures of genistein and either of them. We employed human
cell line of fibroblasts, which should open new possibilities
to assess cell cycle regulatory processes operating in nor-
mal, untransformed, cells. The use of a cell culture model
that exhibits a finite proliferative capacity has the advan-
tage of providing a controlled environment to study a wide
variety of cellular phenomena. It has also the inherent
limitation of isolating cells from the regulatory elements
that might be provided by other types of cells. Among
different cells types (such as glial cells, keratinocytes,
vascular smooth muscle cells, lens cells, endothelial cells,
lymphocytes, liver, and melanocytes), fibroblasts from
normal individuals exhibit most limited replicative life-s-
pan in the culture and therefore remain a powerful tool for
a variety of studies.
We assumed that such studies have to contribute to both
extending our basic knowledge on the influence of flavo-
noids on human cell cycle and identifying potential adverse
effects on these compounds (used in various therapies) in
normal cells. To address these issues, we utilized tran-
scriptomic approach, i.e., a microarray gene profiling and a
real-time quantitative Reverse Transcription PCR (real-
time qRT-PCR) to examine gene expression, as well as cell
viability and cell cycle progression tests to study devel-
opment of fibroblasts exposed to different concentrations of
tested compounds.
Materials and methods
Cell lines, culture media, supplements, and flavonoid
solutions
Human Dermal Fibroblasts, adult (HDFa) (Cascade
Biologics, Portland, USA) were cultured in Dulbecco’s
modified Eagle’s medium (DMEM, Sigma-Aldrich, Stein-
heim, Germany) supplemented with 10 % fetal bovine
serum (FBS) and 1 % antibiotic/antimycotic solution
(Sigma-Aldrich, Steinheim, Germany), at 37 C and 5 %
CO2. Genistein was synthesized at the Pharmaceutical
Research Institute (Warsaw, Poland), while kaempferol and
daidzein were obtained from Sigma-Aldrich (Steinheim,
Germany). Tested flavonoids were dissolved in dimethyl
sulfoxide (DMSO) and added to cell cultures at the indi-
cated final concentrations as determined in previous studies
[20, 21]. For experimental procedures, cells were plated at
approximately 80 % confluence. After overnight incuba-
tion, culture medium was replaced with fresh medium
either flavonoid-free, containing DMSO at a final concen-
tration of 0.05 % (control, K), or the one supplemented with
appropriate amount of tested flavonoids. The experimental
treatment was 24 and 48 h period.
RNA extraction
Total RNA was extracted from cells using the High Pure
RNA Isolation Kit (Roche Applied Science, Indianapolis,
USA) following the manufacturer’s instructions. The
quality and quantity of each RNA sample was evaluated
using the RNA 6000 Nano Assay on the Agilent 2100
Bioanalyser (Agilent Technologies Inc., USA).
Microarray assays for mRNA analysis
Whole genome microarray analysis of three biological
replicates (n) was performed using Illumina’s Human HT-
12v4 Expression BeadChips (Illumina Inc., USA). The
assay performance, data extraction, and statistical analysis
were performed as previously described [19]. Gene On-
tology analysis and data visualization were performed us-
ing the web tools GOrilla (http://cbl-gorilla.cs.technion.ac.
il/) and REViGO (http://revigo.irb.hr/) restricting the out-
put to biological process and cell compartment. Gene set
enrichment analysis (GSEA) was performed on the up-
regulated and down-regulated gene lists, separately as
previously described [22, 23]. A nominal P value\0.01
and a false discovery rate (FDR)\0.25 were used to assess
the significance of the enrichment scores. The microarray
expression data used in this study have GEO accession
numbers GSE34074 and GSE43692.
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Real-time quantitative RT-PCR array for mRNA
analysis
Total RNA was retrotranscribed with Transcriptor First-
Strand cDNA Synthesis Kit (Roche Applied Science, In-
dianapolis, USA). Real-time qRT-PCR was carried out
with Real-Time ready Custom Panel (cat no. 05532914001,
config. no. 100064133; Roche Applied Science, Indi-
anapolis, USA) and the LightCycler 480 Probes Master
(Roche Applied Science, Indianapolis, USA) using the
Light Cycler 480 II detection system (Roche). Expression
values were normalized against three control genes B2M,
GAPDH, and RPLP0 of constant expression level. For both
microarray and real-time qRT-PCR analyses, a fold change
(FC) greater or equal to 1.3 and below 0.7 was considered
as a relevant criterion for genes being significantly differ-
entially expressed.
Cytotoxicity and proliferation assay
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazoli-
um bromide) assay was performed to estimate cell growth
and proliferation. Cells were plated in flat-bottomed
96-well plates and treated with 30, 60, and 100 lM of
genistein or 0.05 % DMSO as control for 24, 48, 72 h, and
7 days at 37 C. After incubation period, medium was re-
placed with RPMI (Sigma-Aldrich) supplemented with
MTT (1 mg/ml) for another 4 h. The purple formazan
crystals were dissolved in 150 ml DMSO, and absorbance
was determined at 570 nm using Wallac 1420 Multilabel
Counter (Perkin Elmer).
Cell viability assessment
105 fibroblasts were seeded in triplicate in 6-well plates.
The medium was changed the following day and supple-
mented with 30, 60, and 100 lM of genistein or 0.05 %
DMSO as control for 24, 48, and 72 h. Cells were counted,
and viability was estimated by MUSE Cell Analyzer
(Merck Millipore, Germany) and Muse Count & Viability
Assay Kit (Merck Millipore, Germany). An average of
2000 cells was analyzed for each condition.
Fibroblast migration assay
To study the effect of genistein on cell migration, 5 9 104
fibroblasts were seeded in triplicate in 6-well plates. The
dishes were incubated at 37 C until cells reach 100 %
confluence to form a monolayer. A pipet tip was used to
create a scratch of the cell monolayer, after that the plate
was washed once and replaced with the desired medium,
i.e., supplemented with 30, 60, and 100 lM of genistein or
0.05 % DMSO as control. The rate of cell migration was
determined for the cells by measuring the distance traveled
during the desired time frame of incubation, i.e., at 0, 6, 12,
18, and 24 h.
Cell cycle assay
The effect of flavonoids on cell cycle was evaluated by
seeding fibroblasts into 6-well plates at a density of
1 9 104 cells per well. After 24 h, the medium was re-
placed with fresh one containing flavonoids. Cell cycle
phase was determined by MUSE Cell Analyzer (Merck
Millipore, Germany) using a Muse Cell Cycle Assay Kit
(Merck Millipore, Germany) according to the manufac-
turer’s instructions. An average of 10,000 cells was ana-
lyzed for each condition. Triplicate independent
experiments were conducted.
Results
Microarray expression analysis of cell cycle
regulation and/or DNA replication-related genes
Whole genome microarray analysis of gene expression was
performed in our prior experiments with human fibroblasts
treated with genistein, daidzein, kaempferol, and their
mixtures ([19]; GEO accession numbers GSE34074 and
GSE43692). In this work, cell cycle and/or DNA replica-
tion-related genes (retrieved from: GO:0000278—mitotic
cell cycle; KEGG:hsa04110—cell cycle; GO:0055133—
DNA replication; KEGG:hsa03030—DNA replication)
were filtered based on desired patterns of expression, up-
and down-regulation at various experimental condi-
tions. 157 genes (42 up- and 115 down-regulated) among
213 belonging to cell cycle and/or DNA replication tran-
scripts revealed modulated activity upon at least a single
type of experimental conditions (Table 1).
Among the tested flavonoids, genistein, kaempferol, and
their mixture belonged to the treatment conditions re-
sponsible for the highest number of genes with modulated
expression in fibroblasts after both 24 and 48 h (Table 2).
In total, 77, 60, and 23 transcripts for 24 h and 68, 95, and
91 for 48 h handling with 100 lM genistein, 100 lM
kaempferol, and mix of genistein with kaempferol (30 lM
each), respectively, were affected.
Interpretation of biological meaning of defining cell
cycle- and DNA replication-associated gene sets was per-
formed by GSEA analysis. The results showed a significant
enrichment among these genes regulated by genistein,
kaempferol, and genistein–kaempferol mix (Fig. 1), with
normalized Enrichment Score stronger than in the case of
daidzein and genistein–daidzein treatment (data not
shown).
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Furthermore, the analysis of ‘Cellular Compartment’ as
well as ‘Biological Processes’ terms revealed that among
all tested conditions, treatment respectively with genistein,
kaempferol, and genistein–kaempferol mix altered sig-
nificantly the expression of cell cycle- and DNA replica-
tion-related genes (Fig. 2). These enrichments for these
categories were noticeably stronger than those observed
when daidzein or genistein–daidzein mix were applied
(data not shown).
Real-time qRT-PCR expression analysis of selected
genes
Relative activity of 44 cell cycle and/or DNA replication-
related genes, selected previously in the course of mi-
croarray analysis, in HDFa fibroblasts treated for 24 h with
100 lM genistein were examined by real-time qRT-PCR
(Table 3). A custom-made human cell cycle profiler PCR
array plate was utilized to assess the expression levels of
particular genes and to validate microarray data. We
confirmed considerable down-regulation of expression of
most genes tested, with only four activated transcripts
(CDKN1A, CDKN1C, CDKN2B, and GADD45A) in re-
sponse to 100 lM genistein after 24 h period of its action.
Among these 44 genes, either up or down-regulated, three,
i.e., MCM8, CDKN2A, and CDKN2C gave different re-
sponses in both DNA microarray and real-time qRT-PCR
analyses.
Cytotoxicity of genistein and its effect on migration
and growth of fibroblasts and cell cycle progression
To investigate the cytotoxicity effect of genistein, we
measured metabolic activity of HDFa cells treated with
different concentrations (30, 60, and 100 lM) of genistein
for different periods of time (24, 48, and 72 h). The cyto-
toxicity assessed as LC25, 50, and 75 is described in
Table 4. The lethal concentration values were[100 lM,
except for LC25 values of 59 and 41 lM genistein after 48-
Table 1 Number of genes related to cell cycle and/or DNA
replication process with expression modulated in HDFa cells by
tested flavonoids or their mixtures at least in one experimental
condition with respect to total number of genes key to cell cycle and/
or DNA replication regulation analyzed with microarrays
Genes Biological process
Cell cycle and/or replication Cell cycle Replication
No. of genes
Total (regulated and un-regulated) 213 128 112
Regulated 157 93 86
Up-regulated 42 29 17
Down-regulated 115 64 69
The fold change of gene expression ratios was C1.3 and B0.7, with a P value\0.05 corrected by false discovery rate, and n C 3 were considered
for flavonoid-treated cells against DMSO-treated samples
Table 2 Number of genes altered as a function of the treatment type
No. of genes
Gene expression
modulation
Genistein Kaempferol Genistein?kaempferol Daidzein Genistein?daidzein
Concentration (lM)
30 60 100 30 60 100 30 ? 30 60 100 30 ? 30
Time of exposure (h)
24 48 24 48 24 48 24 48 24 48 24 48 24 48 24 48 24 48 24 48
In sum 17 29 60 50 77 68 69 82 43 91 60 95 23 91 17 84 12 55 6 65
Up-regulation 2 2 7 7 16 16 9 12 7 16 14 18 13 17 6 10 10 13 5 20
Down-regulation 15 27 53 43 61 52 60 70 36 75 46 77 10 74 11 74 2 42 1 45
Genes key to cell cycle and DNA replication regulation with expression modulated in HDFa cells upon flavonoid treatment were obtained from
microarray analysis against DMSO-treated samples
Alterations in mRNA level of selected genes were considered as 0.7 C FC C 1.3, with a P value\0.05, and n C 3
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Fig. 1 GSEA analysis of cell cycle-related (a) and DNA replication
regulation (b) gene sets enriched among genes up- and down-
regulated by 100 lM genistein (GEN), 100 lM kaempferol (KAEM),
and mixture of them (GEN ? KAEM) at 30 lM each, for 24 and
48 h in HDFa fibroblasts. Graphs show the enrichment plots
generated by GSEA analysis of ranked gene expression data (left
up-regulated, red; right down-regulated, blue). The enrichment score
is shown as a green line, and the vertical black bars below the plot
indicate the position of cell cycle or DNA replication regulation-
associated genes, which are mostly grouped in the fraction of down-
regulated genes. (Color figure online)
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and 72-h incubation periods, respectively. The viability of
fibroblasts was additionally assessed with the use of auto-
mated cell analyzer system. As seen in Fig. 3, the cell
viability did not change remarkably at the tested
conditions, although the total cell number was reduced.
Moreover, the growth inhibitory effect of genistein was
studied in HDFa cells treated with various concentrations
(30, 60, and 100 lM) of compound for 7 days (Fig. 4). It
B GEN48hGEN24h
KEAM48hKAEM24h
GEN+KAEM24h GEN+KEAM48h 
Fig. 1 continued
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Fig. 2 GO analysis by ‘Cellular
Compartment’ and ‘Biological
Processes’ category of genes
with down-regulated expression
upon flavonoids’ treatment
(100 lM genistein, 100 lM
kaempferol, and mixture of
them of 30 lM each, for 24 and
48 h) of HDFa cells, with false
discovery rate (FDR)\0.1, fold
change C1.3 and below 0.7, and
P\ 0.001. All cell cycle
regulation and/or DNA
replication relevant cellular
compartments and processes are
marked in black, while
everything else is white
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should be noted that the anti-proliferative activity of
genistein is concentration dependent.
In addition, the analysis of genistein effect on fibroblast
migration by in vitro scratch assay showed acceleration of
movement of cells treated with this isoflavone when cou-
pled with control untreated fibroblasts, with time- and
dose-dependent alterations (Table 5), thus revealing in vit-
ro wound healing properties of genistein.
Besides, the effect of genistein on cell cycle progression
of HDFa fibroblasts after 24, 48, and 72 h following the
addition of this isoflavone was examined. As shown in
Fig. 5, in fibroblasts treated with 60 and 100 lM genistein,
the percentage of G0/G1 cells initially (at 24 h) increased
in respect to DMSO and 30 lM genistein and thereafter
gradually decreased after 48 and 72 h; on the contrary,
there was induction of untreated cells. As to the S phase,
genistein slightly decreased the population of HDFa fi-
broblasts in a dose-dependent manner, while it induced cell
number in the G2/M phase, especially at 72 h. The con-
centrations greater than 30 lM genistein were necessary to
alter cell cycle progression, with maximal accumulation of
G2/M cells observed at 100 lM. However, the increasing
percentage of cells in G2/M stage in response to growing
concentration of genistein at 72 h may also result from
anti-proliferative effect of the tested compound (Table 4).
Discussion
Selected flavonoids were used in cell culture studies to
examine their effect on cell cycle and DNA replication.
Plant metabolites are compounds met by human cells as
humans usually take them with food. Moreover, some of
these compounds are either used or proposed for the use in
various therapeutic approaches, since they may sig-
nificantly influence physiology of humans. This is plausible
as many plant metabolites have various biological ac-
tivities, which are, however, rather poorly understood at the
molecular level. Therefore, we aimed to investigate
mechanisms of influence of these substances on cell divi-
sion cycle and DNA replication in exemplar eukaryotic
system–normal human fibroblasts. We have chosen flavo-
noids as results of previous studies indicating that they can
significantly influence DNA synthesis (see below). The
idea to use fibroblasts from a healthy individual arose from
the fact that vast majority of studies on effects of flavo-
noids are performed on cancer cells. What is more, the
knowledge regarding the influence of flavonoids on human
cell cycle and DNA replication in normal cells, especially
in non-neoplastic fibroblasts, is desired as these compounds
have extensive medical significance and are used for
treatment of some common diseases, due to their proven
Fig. 2 continued
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Table 3 Validation of microarray data of selected cell cycle- and/or DNA replication-related genes in HDFa cells by real-time qRT-PCR array
Cell cycle genes with modulated expression (44) Protein FC – SD
(microarray)
FC – SD (plate
qRT-PCR)
G1 Phase and G1/S transition (3)
CDC7 Cell division cycle 7 0.52 – 0.1 0.28 – 0.1
CDKN1A (p21) Cyclin-dependent kinase inhibitor 1A 2.34 ± 0.2 1.47 ± 0.2
CDKN1C (p57) Cyclin-dependent kinase inhibitor 1C 1.46 ± 0.3 1.30 ± 0.3
S Phase and DNA replication (14)
CDT1 Chromatin licensing and DNA replication factor 1 0.43 – 0.1 0.23 – 0.0
FEN1 Flap structure-specific endonuclease 1 0.43 – 0.1 0.19 – 0.0
GINS2 GINS complex subunit 2 0.34 – 0.0 0.20 – 0.0
GINS3 GINS complex subunit 3 0.40 – 0.1 0.15 – 0.0
GMNN Geminin, DNA replication inhibitor 0.62 – 0.1 0.24 – 0.0
MCM2 Minichromosome maintenance complex component 2 0.48 – 0.0 0.20 – 0.0
MCM3 Minichromosome maintenance complex component 3 0.52 – 0.0 0.28 – 0.1
MCM4 (CDC21) Minichromosome maintenance complex component 4 0.43 – 0.1 0.30 – 0.0
MCM5 (CDC46) Minichromosome maintenance complex component 5 0.41 – 0.1 0.23 – 0.0
MCM6 (Mis5) Minichromosome maintenance complex component 6 0.61 – 0.0 0.37 – 0.0
MCM7 (CDC47) Minichromosome maintenance complex component 7 0.54 – 0.0 0.28 – 0.0
MCM8 Minichromosome maintenance complex component 8 1.41 – 0.2 0.27 – 0.0
MCM10 Minichromosome maintenance complex component 10 0.40 – 0.1 0.28 – 0.0
POLE DNA polymerase epsilon subunit 1 0.54 – 0.1 0.33 – 0.0
POLE2 DNA polymerase epsilon subunit 2 0.53 – 0.1 0.32 – 0.0
TOP2A DNA topoisomerase 2 alpha 0.69 – 0.2 0.13 – 0.0
G2 phase and G2/M transition (6)
BIRC5 (CPC) Survivin, baculoviral IAP repeat-containing protein 5
(Chromosomal Passenger Complex)
0.39 – 0.1 0.10 – 0.0
CCNA1 Cyclin A1 0.78 – 0.0 0.32 – 0.2
CCNB1 Cyclin B1 0.42 – 0.1 0.08 – 0.0
CDK2 Cyclin-dependent kinase 2 0.44 – 0.0 0.21 – 0.1
PLK1 Polo-like kinase 1 0.38 – 0.1 0.05 – 0.0
TPX2 Microtubule-associated targeting protein for Xklp2 0.33 – 0.0 0.09 – 0.0
M Phase (3)
CCNB2 Cyclin B2 0.51 – 0.1 0.10 – 0.0
CCNB3 Cyclin B3 0.38 – 0.0 0.65 – 0.2
CDC20 Cell division cycle 20 0.42 – 0.1 0.08 – 0.0
Cell cycle checkpoint and cell cycle arrest (14)
CCNA2 Cyclin A2 0.44 – 0.1 0.11 – 0.0
CDC45L Cell division cycle 45-like 0.33 – 0.0 0.21 – 0.0
CDK2 Cyclin-dependent kinase 2 0.44 – 0.0 0.21 – 0.1
CDKN1A (p21) Cyclin-dependent kinase inhibitor 1A 2.34 ± 0.2 1.47 ± 0.2
CDKN1C (p57) Cyclin-dependent kinase inhibitor 1C 1.46 ± 0.3 1.30 ± 0.3
CDKN2A (p16) Cyclin-dependent kinase inhibitor 2A 2.04 – 0.0 0.50 – 0.1
CDKN2B (p15) Cyclin-dependent kinase inhibitor 2B 1.34 ± 0.1 1.39 ± 0.1
CDKN2C (p18) Cyclin-dependent kinase inhibitor 2C 1.23 – 0.2 0.12 – 0.0
CDKN2D (p19) Cyclin-dependent kinase inhibitor 2D 0.70 – 0.2 0.15 – 0.0
CHEK1 (CHK1) cell cycle checkpoint kinase 1 0.38 – 0.0 0.26 – 0.0
CHEK2 (CHK2 / RAD53) Cell cycle checkpoint kinase 2 0.67 – 0.1 0.56 – 0.0
GADD45A (DDIT4) Growth arrest and DNA-damage-inducible 45
(DNA-damage-inducible transcript 1)
1.55 ± 0.3 1.78 ± 0.6
RB1 Retinoblastoma 1 0.61 – 0.0 0.40 – 0.1
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ability to inhibit specific enzymes, to simulate some hor-
mones and neurotransmitters, and to scavenge free radicals.
In our study, genistein gave the most spectacular re-
sults. It was suggested previously that inhibition of DNA
replication by this compound may be due to inactivation
of DNA topoisomerases ([3] and references therein).
Moreover, genistein was demonstrated to induce the arrest
of the cell cycle in cancer cells [11]. We performed
systematic studies to recognize pathways leading to the
final effect of cell cycle and DNA replication impairment
by genistein and other flavonoids. The transcriptome of
the cell line HDFa was profiled with Illumina’s Human
HT-12 v3 Expression BeadChips. Since genistein gave the
most interesting results, this isoflavone was studied in
more detail.
We confirmed that genistein influences cell cycle control
in the human fibroblast model. More importantly, the results
from DNA microarrays were confirmed by an independent,
quantitative method, the real-time Reverse Transcription
PCR. Both microarray and real-time qRT-PCR analyses
indicated that genistein significantly influences expression of
many genes involved in cell cycle control at its various
stages and DNA replication regulation (Table 3).
Table 3 continued
Cell cycle genes with modulated expression (44) Protein FC – SD
(microarray)
FC – SD (plate
qRT-PCR)
TP53 (p53) Tumor protein 53 0.59 – 0.1 0.74 – 0.1
Regulation of the cell cycle (10)
CCNA1 Cyclin A1 0.78 – 0.0 0.32 – 0.2
CCNA2 Cyclin A2 0.44 – 0.1 0.11 – 0.0
CCNB1 Cyclin B1 0.42 – 0.1 0.08 – 0.0
CCNB2 Cyclin B2 0.51 – 0.1 0.10 – 0.0
CDC20 (p55cdc) Cell division cycle 20 0.42 – 0.1 0.08 – 0.0
CDC45L Cell division cycle 45-like 0.33 – 0.0 0.21 – 0.0
CDK2 Cyclin-dependent kinase 2 0.44 – 0.0 0.21 – 0.1
E2F2 E2F transcription factor 0.30 – 0.1 0.16 – 0.0
GADD45A (DDIT4) Growth arrest and DNA-damage-inducible 45
(DNA-damage-inducible transcript 1)
1.55 ± 0.3 1.78 ± 0.6
RB1 retinoblastoma 1 0.61 – 0.0 0.40 – 0.1
Negative regulation of the cell cycle (4)
CDC7 Cell division cycle 7 0.52 – 0.1 0.28 – 0.1
CDKN2B (p15) Cyclin-dependent kinase inhibitor 2B 1.34 ± 0.1 1.39 ± 0.1
CDKN2D (p19) Cyclin-dependent kinase inhibitor 2D 0.70 – 0.2 0.15 – 0.0
TP53 (p53) tumor protein 53 0.59 – 0.1 0.74 – 0.1
Chromosome segregation (3)
BIRC5 (CPC) Survivin, baculoviral IAP repeat-containing protein 5
(Chromosomal Passenger Complex)
0.39 – 0.1 0.10 – 0.0
CENPA Centromere protein A 0.37 – 0.1 0.06 – 0.0
INCENP Inner centromere protein antigens 0.67 – 0.1 0.15 – 0.0
Mitotic checkpoint regulators/spindle assembly checkpoint (SAC) (2)
BUB1 Mitotic checkpoint serine 0.26 – 0.1 0.10 – 0.0
TTK TTK protein kinase 0.46 – 0.1 0.10 – 0.0
The microarray and real-time qRT-PCR array data represent fold change (FC, greater or equal to 1.3, and below 0.7, with P\0.001) averaged
values ±SD from n C 3 and denote significant differences for samples treated with 100 lM genistein against non-treated samples for 24 h, with
respect to reference gene GAPDH of constant expression level
The symbols of genes that were down-regulated are bolded in italic and up-regulated normal in italic
Table 4 Cytotoxic activity of genistein expressed as LC25, 50, or 75
index value, i.e., concentration of the tested compound (lM) that is
lethal to 25, 50, or 75 % of cells in a culture exposed to genistein for
24, 48, and 72 h
Time of exposure (h) LC25 (lM) LC50 (lM) LC75 (lM)
24 [100 [100 [100
48 59 [100 [100
72 41 91 [100
106 Mol Cell Biochem (2015) 407:97–109
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Genistein is known to inhibit proliferation of human
cancer cells [13], which made it a potential anti-cancer
therapeutic. Importantly, at concentrations low enough to
influence cancer cells, there is only a minor effect on
normal cells. As it has attracted attention because of its
beneficial effects on prevention of metabolic disorders re-
lated to cardiovascular disease (CVD), obesity, and also
diabetes, the side effects and warnings of genistein have
ever been considered. Some results could suggest that
genistein might impair immunity by its negative effects on
mouse thymus gland and various white blood cells [24].
Moreover, in vitro studies have shown genistein to induce
apoptosis of testicular cells at certain levels, thus raising
concerns about effects it could have on male fertility [25].
However, a recent work indicated that isoflavones had no
observable effect in healthy males given isoflavone sup-
plements daily over a 2-month period [26]. Similarly, no
significant adverse effects of genistein were observable in
studies on two other groups, even when treatment with this
isoflavone was as long as 6 or 12 months [27, 28].
The hypothesis on halting of DNA replication through
genistein-mediated inhibition of topoisomerase activity,
presented for the bacterial model, was also extended to
eukaryotic cells [17]. However, our transcriptomic studies
indicated that in human cells cultured in the presence of
genistein, no alterations in activity of all four genes,
TOPA1, TOPA2, TOPB1, and TOPB2, encoding for DNA
Fig. 3 Determination of count and viability of HDFa cells treated
with 30, 60, and 100 lM genistein for 24, 48, and 72 h. Data are
represented as mean, and bars show SD values of experiments run in
triplicate. Cell count test gave statistical differences among ex-
perimental groups using one-way ANOVA followed by Tukey’s HSD
Post-Hoc (P\ 0.00001), while for cell viability, no significant
alterations were detected except for cells treated for 72 h with 60 and
100 lM genistein versus control with significance value of P\ 0.05
as determined by one-way ANOVA
Fig. 4 Effect of genistein on growth of HDFa fibroblasts determined
for cultures treated for 7 days with the tested compound of 30, 60, and
100 lM, and calculated as ratio, comparing to the DMSO-treated
control. Data are presented as mean values ±SD from at least
triplicate wells and three independent experiments
Table 5 The effect of genistein
on the migration of fibroblasts
in a culture supplemented with
30, 60, and 100 lM of genistein
or 0.05 % DMSO as control
Genistein (lM) Fibroblast migration (% of distance travelled by control cells)
0 h 6 h 12 h 18 h 24 h
30 121 ± 13 96 ± 31 100 ± 37 99 ± 41 113 ± 53
60 111 ± 15 107 ± 28 114 ± 36 102 ± 40 115 ± 53
100 110 ± 16 106 ± 23 115 ± 31 120 ± 35 143 ± 65
The rate of cell migration was determined for the cells by measuring the distance traveled during the
desired time frame of incubation, i.e., at 0, 6, 12, 18, and 24 h
The data represent averaged values ±SD of experiments run in triplicate from at least 100 measurements
and are denoted as % of control
Statistical differences among all experimental groups using one-way ANOVA followed by Tukey’s HSD
Post-Hoc (P\ 0.00001) were observed
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topoisomerase were observed. On the contrary, the effi-
ciency of expression of genes coding for MCM2-7 and
MCM10 helicases, as well as some other proteins involved
in the S phase control, was significantly reduced (Table 3).
This may indicate that effects of genistein on DNA repli-
cation are not only restricted to its action on topoiso-
merases, but also include down-regulation of expression of
genes required for DNA synthesis. Furthermore, levels of
mRNA of genes coding for proteins involved in
chromosome segregation were also less abundant in the
presence of genistein.
Interestingly, we found that genistein modulates (in most
cases down-regulates, but in some up-regulates) expression
of a relatively large group of genes, whose products are
involved in different phases of the cell cycle (the G1 phase
and G1/S phase transition, G2 phase, and G2/M phase
transition, M phase), as well as in regulatory processes, like
cell cycle checkpoint and cell cycle arrest, mitotic check-
point, and spindle assembly checkpoint. Some recent reports
also indicated that genistein influences expression of such
genes. For example, up-regulation of expression of p21
(CDKN1A) in prostate cancer cells has been described pre-
viously [29], and similar results are shown here in normal
human fibroblasts. Increased expression of BDNF was de-
tected in genistein-treated hippocampus neuronal cells [30],
and decreased levels of the miR-223, a hematopoietic-
specific microRNA with crucial function in myeloid lineage
development, promoting granulocytic and suppressing ery-
throcytic differentiation, were found in pancreatic cancer
cells in response to this isoflavone [31]. Moreover, in ac-
cordance to results presented in this study, genistein was
found to induce G2/M cell cycle arrest and apoptosis of
human ovarian cancer cells via activation of DNA damage
checkpoint pathways [8].
Genistein is known as an inhibitor of various kinases,
such as serine, threonine, tyrosine, histidine protein ki-
nases, and the HER-2 kinase [32]. This isoflavone has been
shown to inhibit the activation of NF-jB and Akt signaling
pathways, both of which are important for cell survival via
maintaining a homeostatic balance between cell survival
and apoptosis. Therefore, it is likely that modulation of
expression of genes shown in Table 3 is due to genistein-
mediated inhibition of particular signal transduction
pathways.
In conclusion, our results of transcriptomic analysis
supported by real-time qRT-PCR, obtained with the human
fibroblasts model, together with results of other researchers
who focused on particular genes in other cells, indicate that
genistein may regulate cell cycle and DNA replication in
human cells due to modulation of expression of a relatively
large group of genes whose products are involved in these
processes. This regulation may also be accompanied by
direct action of genistein on important proteins, like
topoisomerases or cyclins; however, this assumption re-
quires further verification.
Acknowledgments This work was supported by National Science
Centre (project Grant Nos. UMO-2011/01/B/NZ1/03686, MAES-
TRO/2011/02/A/NZ1/00009).
Conflict of interest The authors declare that they have no conflict
of interest.
* 
*
* 
** 
**
**
**
ns
*
*
**
*
**
ns 
**
*
**
*
*
**
**
**
**
**
**
Fig. 5 Effect of genistein on cell cycle progression in HDFa
fibroblasts. After 24, 48, and 72 h from the addition of 30, 60, or
100 lM genistein, the percentage of G0/G1, S, and G2/M was
calculated. Data are presented as a ratio of total cells counted and
represent mean values ±SD of at least triplicate experiments.
Comparisons among groups were performed using a one-way
ANOVA with Tukey HSD Post-Hoc (*P B 0.05 and **P B 0.001).
Ns stands for not significant
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